| HIV Vaccine Reported Successful in Human Trials Sergio N. Candido - SFGN | |
| go to original September 6, 2013 |
|

A new vaccine developed by Canadian researchers to prevent HIV has passed the first phase of human testing.
According to the Ontario Business Report, the team, from the Schulich School of Medicine & Dentistry at Western University, succeeded on the first phase of trials, even boosting the production of antibodies in patients it was tested on.
Lead researcher Dr. Chil-Yong Kang said the vaccine is based on a genetically-modified ‘dead’ version of the virus.
“We infect the cells with a genetically modified HIV-1,” team leader Dr. Chil-Yong Kang told Ontario Business Report. “The infected cells produce lots of virus, which we collect, purify and inactivate so that the vaccine won’t cause AIDS in recipients, but will trigger immune responses.”
Read the rest at SFGN
Photo by Ontario Business Report
We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!
From activities like hiking, swimming, bike riding and yoga, to restaurants offering healthy menus, Vallarta-Nayarit is the ideal place to continue - or start - your healthy lifestyle routine.